Translational medicine in familial Hypercholesterolaemia – from Phenotype to Genotype to Treatment: Mechanism  of disease and research effort

Publicação

dc.contributor.author	Bourbon, Mafalda
dc.date.accessioned	2019-02-22T18:00:40Z
dc.date.available	2019-02-22T18:00:40Z
dc.date.issued	2018-11
dc.description	Comunicação a convite	pt_PT
dc.description.abstract	Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipid metabolism characterized by elevated levels of LDL-C and increased cardiovascular risk.	pt_PT
dc.description.version	N/A	pt_PT
dc.identifier.uri	http://hdl.handle.net/10400.18/5934
dc.language.iso	eng	pt_PT
dc.publisher	Instituto Nacional de Saúde Doutor Ricardo Jorge, IP	pt_PT
dc.subject	Familial Hypercholesterolemia	pt_PT
dc.subject	Personalized Medicine	pt_PT
dc.subject	Portuguese FH study	pt_PT
dc.subject	Dyslipidemia	pt_PT
dc.subject	Doenças Cardio e Cérebro-vasculares	pt_PT
dc.title	Translational medicine in familial Hypercholesterolaemia – from Phenotype to Genotype to Treatment: Mechanism of disease and research effort	pt_PT
dc.type	conference object
dspace.entity.type	Publication
oaire.citation.conferencePlace	Berlin, Germany	pt_PT
oaire.citation.title	ICPerMed Conference 2018 'Personalised Medicine in Action', 3rd Best Practice Example of Personalised Medicine Research & Implementation - From Basic Research to the Patient: Translational medicine in familial Hypercholesterolaemia – from Phenotype to Genotype to Treatment, 20-21 november 2018	pt_PT
rcaap.rights	embargoedAccess	pt_PT
rcaap.type	conferenceObject	pt_PT

Ficheiros

A mostrar 1 - 1 de 1

A mostrar 1 - 1 de 1